Cargando…

Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas

BACKGROUND: This is a literature review aiming to provide an update about the recent findings related to the efficacy of middle meningeal artery embolization (MMAE) in the treatment of chronic subdural hematomas (cSDHs), comparison with conventional therapy and deduction of the current recommendatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Msheik, Ali, Fares, Youssef, Mohanna, Mohammad, Aoude, Ahmad, Shkeir, Mohamad, Chehade, Feras, Kanj, Ali, Mohanna, Assaad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990792/
https://www.ncbi.nlm.nih.gov/pubmed/36895214
http://dx.doi.org/10.25259/SNI_1096_2022
_version_ 1784902011096924160
author Msheik, Ali
Fares, Youssef
Mohanna, Mohammad
Aoude, Ahmad
Shkeir, Mohamad
Chehade, Feras
Kanj, Ali
Mohanna, Assaad
author_facet Msheik, Ali
Fares, Youssef
Mohanna, Mohammad
Aoude, Ahmad
Shkeir, Mohamad
Chehade, Feras
Kanj, Ali
Mohanna, Assaad
author_sort Msheik, Ali
collection PubMed
description BACKGROUND: This is a literature review aiming to provide an update about the recent findings related to the efficacy of middle meningeal artery embolization (MMAE) in the treatment of chronic subdural hematomas (cSDHs), comparison with conventional therapy and deduction of the current recommendations and indications. METHODS: The literature is reviewed using a search through the PubMed index using keywords. Studies are then screened, skimmed, and thoroughly read. 32 studies fulfilled the inclusion criteria and are included in the study. RESULTS: Five indications for the application of MMA embolization (MMAE) are deducted from the literature. The usage as a preventive measure after surgical treatment of symptomatic cSDHs in patients with a high risk of recurrence and the usage as a standalone procedure has been the most common reasons for indication of this procedure. Rates of failures for the aforementioned indications have been 6.8% and 3.8%, respectively. CONCLUSION: The safety of MMAE as a procedure is regarded as a general theme in the literature and can be considered for future applications. Usage of this procedure in clinical trials with more patient segregation and timeframe assessment relative to surgical intervention are recommendations of this literature review.
format Online
Article
Text
id pubmed-9990792
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-99907922023-03-08 Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas Msheik, Ali Fares, Youssef Mohanna, Mohammad Aoude, Ahmad Shkeir, Mohamad Chehade, Feras Kanj, Ali Mohanna, Assaad Surg Neurol Int Review Article BACKGROUND: This is a literature review aiming to provide an update about the recent findings related to the efficacy of middle meningeal artery embolization (MMAE) in the treatment of chronic subdural hematomas (cSDHs), comparison with conventional therapy and deduction of the current recommendations and indications. METHODS: The literature is reviewed using a search through the PubMed index using keywords. Studies are then screened, skimmed, and thoroughly read. 32 studies fulfilled the inclusion criteria and are included in the study. RESULTS: Five indications for the application of MMA embolization (MMAE) are deducted from the literature. The usage as a preventive measure after surgical treatment of symptomatic cSDHs in patients with a high risk of recurrence and the usage as a standalone procedure has been the most common reasons for indication of this procedure. Rates of failures for the aforementioned indications have been 6.8% and 3.8%, respectively. CONCLUSION: The safety of MMAE as a procedure is regarded as a general theme in the literature and can be considered for future applications. Usage of this procedure in clinical trials with more patient segregation and timeframe assessment relative to surgical intervention are recommendations of this literature review. Scientific Scholar 2023-02-24 /pmc/articles/PMC9990792/ /pubmed/36895214 http://dx.doi.org/10.25259/SNI_1096_2022 Text en Copyright: © 2023 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Msheik, Ali
Fares, Youssef
Mohanna, Mohammad
Aoude, Ahmad
Shkeir, Mohamad
Chehade, Feras
Kanj, Ali
Mohanna, Assaad
Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas
title Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas
title_full Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas
title_fullStr Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas
title_full_unstemmed Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas
title_short Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas
title_sort middle meningeal artery embolisation: the review of a new treatment for chronic subdural hematomas
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990792/
https://www.ncbi.nlm.nih.gov/pubmed/36895214
http://dx.doi.org/10.25259/SNI_1096_2022
work_keys_str_mv AT msheikali middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT faresyoussef middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT mohannamohammad middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT aoudeahmad middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT shkeirmohamad middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT chehadeferas middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT kanjali middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas
AT mohannaassaad middlemeningealarteryembolisationthereviewofanewtreatmentforchronicsubduralhematomas